Vaginal progesterone gel versus IM progesterone in IVF-ET Clinical study 02 February 2013 Pages: 13 - 13
Alteplase may be effective for stroke after cardiac catheterisation Clinical study 02 February 2013 Pages: 14 - 14
Metoclopramide has head start on hydromorphone for migraine Clinical study 02 February 2013 Pages: 14 - 14
Telbivudine trumps lamivudine for Chinese with chronic hep B Clinical study 02 February 2013 Pages: 14 - 14
Paroxetine “not superior” to placebo in major depression Clinical study 02 February 2013 Pages: 15 - 15
Vasopressin and norepinephrine comparable for septic shock Clinical study 02 February 2013 Pages: 15 - 15
Local anaesthetics appear to suppress inflammatory action Clinical study 02 February 2013 Pages: 16 - 16
Oral vs IV fluconazole: interactions with IV calcineurin inhibitors Clinical study 02 February 2013 Pages: 16 - 16
Abbreviated New Drug Application approved for carbinoxamine in US. Media release 02 February 2013 Pages: 17 - 17
Actavis has received approval for four generics in the US. Media release 02 February 2013 Pages: 17 - 17
Good news for desvenlafaxine in major depressive disorder Media release 02 February 2013 Pages: 17 - 17
Levofloxacin inhalation solution granted orphan drug status in the US. Media release 02 February 2013 Pages: 17 - 17
Lidocaine/tetracaine has been granted marketing authorisation in Europe Media release 02 February 2013 Pages: 18 - 18
New Drug Application granted priority review for difluprednate in US. Media release 02 February 2013 Pages: 18 - 18
Omeprazole 20mg delayed-release tablets launched in the US. Media release 02 February 2013 Pages: 18 - 18
US FDA issues not approvable letter for istradefylline. Media release 02 February 2013 Pages: 19 - 19
Verapamil receives Japanese approval for additional indications Media release 02 February 2013 Pages: 19 - 19